NASDAQ : VSTM
Verastem, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 9.75 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.18B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.18B |
| Enterprise Value | 1.13B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 121.50M |
| Shares Outstanding | 121.50M |
| Shares Change (YoY) | +69.55% |
| Shares Change (QoQ) | +0.98% |
| Owned by Insiders (%) | 0.54% |
| Owned by Institutions (%) | 70.90% |
| Float | 107.18M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.53 |
| Forward PS | 8.46 |
| PB Ratio | 17.65 |
| P/TBV Ratio | 34.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 12.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.25 |
| Quick Ratio | 2.12 |
| Debt / Equity | 1.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -108.19 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -471.16% |
| Return on Assets (ROA) | -49.59% |
| Return on Invested Capital (ROIC) | -78.30% |
| Return on Capital Employed (ROCE) | -124.47% |
| Weighted Average Cost of Capital (WACC) | 6.05% |
| Revenue Per Employee | $858,098 |
| Profits Per Employee | -$1.99M |
| Employee Count | 102 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 6.07 |
Taxes
| Measure | Value |
|---|
| Income Tax | 816,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +10.80% |
| 50-Day Moving Average | 8.16 |
| 200-Day Moving Average | 6.17 |
| Relative Strength Index (RSI) | 61.69 |
| Average Volume (20 Days) | 5,739,805 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 17.20M |
| Short Previous Month | 14.96M |
| Short % of Shares Out | 14.16% |
| Short % of Float | 16.05% |
| Short Ratio (days to cover) | 3.77 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 87.53M |
| Gross Profit | 76.71M |
| Operating Income | -159.80M |
| Pretax Income | -201.88M |
| Net Income | -202.70M |
| EBITDA | -158.65M |
| EBIT | -159.80M |
| Loss Per Share | -$2.28 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 136.35M |
| Total Debt | 84.33M |
| Net Cash | 52.02M |
| Net Cash Per Share | $0.43 |
| Equity (Book Value) | 49.99M |
| Book Value Per Share | 0.55 |
| Working Capital | 98.03M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -162.20M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.15M |
| Net Borrowing | -2.75M |
| Free Cash Flow | -162.20M |
| FCF Per Share | -$1.33 |
Margins
| Measure | Value |
|---|
| Gross Margin | 87.64% |
| Operating Margin | -182.57% |
| Pretax Margin | -230.65% |
| Profit Margin | -231.59% |
| EBITDA Margin | -181.26% |
| EBIT Margin | -182.57% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -69.55% |
| Shareholder Yield | -69.55% |
| Earnings Yield | -23.41% |
| FCF Yield | -13.69% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $17.11 |
| Price Target Difference | 75.49% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 99.15% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 1, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -8.03 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |